1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Holliger, P.
Riechmann, L.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
90.00
90.00
90.00
1.000
1.000
1.000
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
UK
Structure
STRUE6
2005
0969-2126
5
265
275
10.1016/S0969-2126(97)00184-6
9032075
A conserved infection pathway for filamentous bacteriophages is suggested by the structure of the membrane penetration domain of the minor coat protein g3p from phage fd.
1997
10.2210/pdb1fgp/pdb
pdb_00001fgp
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
7711.479
FD GENE 3 PROTEIN
DOMAIN 1
1
man
polymer
no
no
ETVESCLAKPHTENSFTNVWKDDKTLDRYANYEGCLWNATGVVVCTGDETQCYGTWVPIGLAIPENAAAH
ETVESCLAKPHTENSFTNVWKDDKTLDRYANYEGCLWNATGVVVCTGDETQCYGTWVPIGLAIPENAAAH
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
Inovirus
Enterobacteria phage M13
Escherichia
sample
10864
Enterobacteria phage fd
SUPERNATANT
562
Escherichia coli
PUC119
database_2
pdbx_database_status
pdbx_struct_assembly
pdbx_struct_oper_list
repository
Initial release
Version format compliance
Version format compliance
Database references
Derived calculations
Other
1
0
1997-06-16
1
1
2008-03-24
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_database_status.process_site
Y
BNL
1996-12-10
REL
REL
LOWEST TOTAL ENERGIES
50
15
15N + 13C NOESY-HMQC
6.2
303
K
SEE JRNL REFERENCE.
simulated annealing
BRUNGER
refinement
X-PLOR
structure solution
X-PLOR
500
Bruker
AMX500
GLU
1
n
1
GLU
1
A
THR
2
n
2
THR
2
A
VAL
3
n
3
VAL
3
A
GLU
4
n
4
GLU
4
A
SER
5
n
5
SER
5
A
CYS
6
n
6
CYS
6
A
LEU
7
n
7
LEU
7
A
ALA
8
n
8
ALA
8
A
LYS
9
n
9
LYS
9
A
PRO
10
n
10
PRO
10
A
HIS
11
n
11
HIS
11
A
THR
12
n
12
THR
12
A
GLU
13
n
13
GLU
13
A
ASN
14
n
14
ASN
14
A
SER
15
n
15
SER
15
A
PHE
16
n
16
PHE
16
A
THR
17
n
17
THR
17
A
ASN
18
n
18
ASN
18
A
VAL
19
n
19
VAL
19
A
TRP
20
n
20
TRP
20
A
LYS
21
n
21
LYS
21
A
ASP
22
n
22
ASP
22
A
ASP
23
n
23
ASP
23
A
LYS
24
n
24
LYS
24
A
THR
25
n
25
THR
25
A
LEU
26
n
26
LEU
26
A
ASP
27
n
27
ASP
27
A
ARG
28
n
28
ARG
28
A
TYR
29
n
29
TYR
29
A
ALA
30
n
30
ALA
30
A
ASN
31
n
31
ASN
31
A
TYR
32
n
32
TYR
32
A
GLU
33
n
33
GLU
33
A
GLY
34
n
34
GLY
34
A
CYS
35
n
35
CYS
35
A
LEU
36
n
36
LEU
36
A
TRP
37
n
37
TRP
37
A
ASN
38
n
38
ASN
38
A
ALA
39
n
39
ALA
39
A
THR
40
n
40
THR
40
A
GLY
41
n
41
GLY
41
A
VAL
42
n
42
VAL
42
A
VAL
43
n
43
VAL
43
A
VAL
44
n
44
VAL
44
A
CYS
45
n
45
CYS
45
A
THR
46
n
46
THR
46
A
GLY
47
n
47
GLY
47
A
ASP
48
n
48
ASP
48
A
GLU
49
n
49
GLU
49
A
THR
50
n
50
THR
50
A
GLN
51
n
51
GLN
51
A
CYS
52
n
52
CYS
52
A
TYR
53
n
53
TYR
53
A
GLY
54
n
54
GLY
54
A
THR
55
n
55
THR
55
A
TRP
56
n
56
TRP
56
A
VAL
57
n
57
VAL
57
A
PRO
58
n
58
PRO
58
A
ILE
59
n
59
ILE
59
A
GLY
60
n
60
GLY
60
A
LEU
61
n
61
LEU
61
A
ALA
62
n
62
ALA
62
A
ILE
63
n
63
ILE
63
A
PRO
64
n
64
PRO
64
A
GLU
65
n
65
GLU
65
A
ASN
66
n
66
ASN
66
A
ALA
67
n
67
ALA
67
A
ALA
68
n
68
ALA
68
A
ALA
69
n
69
ALA
69
A
HIS
70
n
70
HIS
70
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
THR
12
A
O
THR
12
A
N
TRP
56
A
N
TRP
56
A
O
GLN
51
A
O
GLN
51
A
N
THR
46
A
N
THR
46
A
O
TRP
20
A
O
TRP
20
A
N
TYR
29
A
N
TYR
29
A
O
ARG
28
A
O
ARG
28
A
N
ALA
39
A
N
ALA
39
A
O
LEU
36
A
O
LEU
36
A
N
GLY
60
A
N
GLY
60
1
A
ARG
28
0.311
SIDE CHAIN
2
A
ARG
28
0.218
SIDE CHAIN
3
A
ARG
28
0.293
SIDE CHAIN
4
A
ARG
28
0.308
SIDE CHAIN
5
A
ARG
28
0.178
SIDE CHAIN
6
A
ARG
28
0.308
SIDE CHAIN
7
A
ARG
28
0.141
SIDE CHAIN
8
A
ARG
28
0.175
SIDE CHAIN
9
A
ARG
28
0.227
SIDE CHAIN
10
A
ARG
28
0.234
SIDE CHAIN
11
A
ARG
28
0.314
SIDE CHAIN
12
A
ARG
28
0.197
SIDE CHAIN
13
A
ARG
28
0.285
SIDE CHAIN
14
A
ARG
28
0.136
SIDE CHAIN
15
A
ARG
28
0.124
SIDE CHAIN
1
A
LYS
9
-46.66
179.90
1
A
HIS
11
69.17
81.40
1
A
THR
12
86.00
-59.34
1
A
GLU
13
-44.84
97.08
1
A
ASN
14
168.53
-149.52
1
A
SER
15
178.83
-173.12
1
A
VAL
19
-46.96
156.42
1
A
LEU
26
70.90
58.97
1
A
ASP
27
170.94
176.77
1
A
GLU
33
35.42
95.59
1
A
THR
40
-101.77
-91.53
1
A
VAL
42
-50.96
89.14
1
A
ILE
59
-154.95
-32.49
1
A
ALA
62
173.11
43.89
1
A
ILE
63
163.15
-36.26
1
A
GLU
65
-72.20
-156.61
1
A
ALA
68
75.62
47.49
2
A
THR
2
67.44
124.56
2
A
LYS
9
-46.92
-179.76
2
A
HIS
11
71.60
81.24
2
A
THR
12
86.14
-59.53
2
A
GLU
13
-44.88
98.94
2
A
ASN
14
167.44
-158.02
2
A
ASN
18
58.32
18.84
2
A
VAL
19
-41.94
153.70
2
A
LEU
26
71.08
62.02
2
A
ASP
27
167.37
170.89
2
A
GLU
33
34.67
93.02
2
A
THR
40
-86.12
-150.43
2
A
GLU
49
81.73
28.18
2
A
ILE
59
-159.34
-32.85
2
A
ALA
62
171.45
52.59
2
A
ILE
63
158.39
-41.55
2
A
GLU
65
-82.64
-154.19
2
A
ASN
66
-91.54
49.89
2
A
ALA
67
179.26
110.30
2
A
ALA
68
-43.25
99.45
3
A
THR
2
57.28
98.41
3
A
LYS
9
-46.01
-178.64
3
A
HIS
11
71.68
81.89
3
A
THR
12
84.89
-59.53
3
A
GLU
13
-44.86
98.95
3
A
ASN
14
165.44
-154.84
3
A
SER
15
-178.65
-170.06
3
A
VAL
19
-48.34
151.21
3
A
LEU
26
70.50
59.28
3
A
ASP
27
168.54
174.72
3
A
GLU
33
35.54
88.78
3
A
VAL
43
-116.01
-167.75
3
A
ILE
59
-150.20
-29.79
3
A
ALA
62
173.32
47.79
3
A
ILE
63
161.78
-38.70
3
A
GLU
65
-61.12
-154.76
3
A
ALA
67
-163.57
-166.96
3
A
ALA
68
58.44
-89.02
4
A
LYS
9
-45.45
179.36
4
A
HIS
11
72.73
81.70
4
A
THR
12
86.28
-58.24
4
A
GLU
13
-44.96
99.02
4
A
ASN
14
165.18
-155.55
4
A
SER
15
-177.20
-171.21
4
A
PHE
16
-176.98
148.45
4
A
VAL
19
-38.94
153.28
4
A
ASP
27
168.16
164.23
4
A
ASN
31
-67.86
96.33
4
A
GLU
33
29.50
81.08
4
A
VAL
42
-63.16
89.33
4
A
VAL
44
-51.18
103.23
4
A
GLU
49
80.29
27.85
4
A
ILE
59
-145.62
-28.30
4
A
ALA
62
171.31
51.37
4
A
ILE
63
159.23
-39.73
4
A
GLU
65
-76.84
-146.73
4
A
ALA
68
-96.65
-151.17
4
A
ALA
69
63.10
100.69
5
A
THR
2
62.86
103.81
5
A
LYS
9
-44.79
-178.19
5
A
HIS
11
73.65
163.43
5
A
THR
12
-12.54
-53.67
5
A
GLU
13
-43.17
97.28
5
A
ASN
14
169.31
-156.92
5
A
SER
15
-174.77
-168.18
5
A
PHE
16
178.23
146.61
5
A
VAL
19
-41.31
163.48
5
A
LEU
26
71.60
67.43
5
A
ASP
27
167.01
167.45
5
A
GLU
33
27.36
81.60
5
A
THR
40
-143.44
-48.48
5
A
VAL
44
-62.10
97.02
5
A
GLU
49
74.82
-2.05
5
A
ILE
59
-144.64
-34.32
5
A
ALA
62
171.70
40.13
5
A
ILE
63
162.18
-36.72
5
A
GLU
65
-78.97
-156.93
6
A
THR
2
44.62
96.10
6
A
ALA
8
-52.04
-72.00
6
A
LYS
9
41.66
-173.67
6
A
HIS
11
71.99
164.18
6
A
THR
12
-13.68
-52.00
6
A
GLU
13
-45.10
98.13
6
A
ASN
14
168.51
-153.28
6
A
SER
15
-179.80
-167.23
6
A
PHE
16
-179.38
141.03
6
A
VAL
19
-39.26
163.15
6
A
LEU
26
65.99
68.89
6
A
ASP
27
164.27
162.11
6
A
GLU
33
-66.41
88.22
6
A
THR
40
-77.85
-154.80
6
A
VAL
42
-105.95
79.65
6
A
ALA
62
-155.09
-68.74
6
A
GLU
65
-81.93
-158.38
6
A
ALA
68
49.78
70.91
7
A
THR
2
71.87
131.19
7
A
LYS
9
-46.51
-178.61
7
A
HIS
11
71.36
167.39
7
A
THR
12
-15.46
-52.80
7
A
GLU
13
-44.74
98.24
7
A
ASN
14
167.48
-150.78
7
A
SER
15
177.57
-169.64
7
A
VAL
19
-40.04
154.53
7
A
LEU
26
65.20
64.61
7
A
ASP
27
170.84
162.93
7
A
GLU
33
38.40
34.27
7
A
THR
40
-60.47
-133.62
7
A
ILE
59
-150.88
-34.24
7
A
ALA
62
167.18
53.55
7
A
ILE
63
161.93
-41.83
7
A
GLU
65
-70.84
-148.50
7
A
ALA
67
173.66
36.37
7
A
ALA
68
-143.30
20.00
8
A
LYS
9
-48.02
-178.70
8
A
HIS
11
71.05
82.03
8
A
THR
12
88.15
-59.25
8
A
GLU
13
-42.77
98.11
8
A
ASN
14
167.84
-154.72
8
A
SER
15
179.37
-173.10
8
A
LEU
26
72.99
59.06
8
A
ASP
27
168.52
169.56
8
A
GLU
33
30.15
77.75
8
A
THR
40
-139.33
-42.10
8
A
ILE
59
-149.34
-32.18
8
A
ALA
62
168.61
42.42
8
A
ILE
63
164.58
-36.75
8
A
GLU
65
-75.35
-163.44
9
A
LYS
9
-46.30
-177.97
9
A
HIS
11
73.31
167.56
9
A
THR
12
-11.40
-54.27
9
A
GLU
13
-43.45
97.35
9
A
ASN
14
169.83
-152.09
9
A
SER
15
-179.17
-171.81
9
A
PHE
16
-173.92
149.07
9
A
VAL
19
-41.75
154.59
9
A
LEU
26
71.61
57.35
9
A
ASP
27
168.15
175.74
9
A
GLU
33
39.33
43.64
9
A
THR
40
-141.25
-41.47
9
A
VAL
44
-56.98
94.04
9
A
ALA
62
172.68
50.76
9
A
ILE
63
158.84
-40.99
9
A
GLU
65
-81.30
-156.68
9
A
ASN
66
-94.96
36.35
9
A
ALA
67
-161.11
-61.12
9
A
ALA
68
175.63
142.45
9
A
ALA
69
-95.47
-146.06
10
A
THR
2
52.87
91.77
10
A
LYS
9
-46.82
-174.59
10
A
HIS
11
72.07
164.44
10
A
THR
12
-11.65
-54.27
10
A
GLU
13
-45.06
97.19
10
A
ASN
14
170.78
-153.46
10
A
SER
15
179.27
174.29
10
A
VAL
19
-41.08
154.96
10
A
LEU
26
76.24
69.64
10
A
ASP
27
169.04
161.42
10
A
TYR
32
-97.60
52.75
10
A
GLU
33
30.93
96.38
10
A
THR
40
-134.82
-68.26
10
A
VAL
44
-52.81
106.28
10
A
ALA
62
173.66
49.42
10
A
ILE
63
163.36
-47.71
10
A
GLU
65
-137.15
-79.94
10
A
ALA
69
50.58
89.11
11
A
LYS
9
-47.80
-176.77
11
A
HIS
11
69.82
81.07
11
A
THR
12
85.60
-57.63
11
A
GLU
13
-44.77
98.29
11
A
ASN
14
165.07
-153.68
11
A
SER
15
177.36
-167.10
11
A
PHE
16
-179.83
139.33
11
A
VAL
19
-47.14
167.25
11
A
LEU
26
64.40
72.08
11
A
ASP
27
162.78
171.34
11
A
THR
40
-63.93
-85.52
11
A
ALA
62
-143.96
-62.13
11
A
GLU
65
-73.93
-167.56
11
A
ASN
66
-97.77
35.00
11
A
ALA
68
52.92
-90.80
11
A
ALA
69
-60.91
89.04
12
A
THR
2
74.61
139.01
12
A
LYS
9
-45.84
178.79
12
A
HIS
11
71.30
166.25
12
A
THR
12
-14.04
-53.05
12
A
GLU
13
-42.51
98.56
12
A
ASN
14
162.99
-156.00
12
A
SER
15
-175.76
-166.97
12
A
PHE
16
179.65
156.80
12
A
ASN
18
58.64
17.82
12
A
VAL
19
-45.70
157.40
12
A
LEU
26
80.89
64.57
12
A
ASP
27
166.29
174.54
12
A
TYR
32
-92.89
50.35
12
A
GLU
33
33.56
94.31
12
A
VAL
42
-60.48
87.76
12
A
GLU
49
79.65
-3.70
12
A
ILE
59
-154.28
-32.55
12
A
ALA
62
172.76
44.94
12
A
ILE
63
164.66
-32.89
12
A
GLU
65
-68.08
-143.01
12
A
ALA
67
163.48
53.52
12
A
ALA
68
-128.43
-93.02
13
A
LYS
9
-45.07
177.44
13
A
HIS
11
72.85
81.11
13
A
THR
12
83.91
-58.84
13
A
GLU
13
-46.12
97.13
13
A
ASN
14
167.96
-148.69
13
A
SER
15
179.27
-169.93
13
A
PHE
16
179.92
148.82
13
A
VAL
19
-49.17
151.49
13
A
LEU
26
82.10
60.92
13
A
ASP
27
160.33
170.72
13
A
GLU
33
34.01
82.84
13
A
THR
40
-135.97
-50.66
13
A
VAL
44
-48.75
101.25
13
A
GLU
49
76.58
-4.89
13
A
ILE
59
-142.23
-34.21
13
A
ALA
62
171.06
52.83
13
A
ILE
63
149.84
-32.53
13
A
GLU
65
-125.03
-169.83
13
A
ALA
67
-49.88
-71.98
13
A
ALA
68
74.63
107.57
13
A
ALA
69
47.33
96.48
14
A
LYS
9
-54.76
-171.76
14
A
HIS
11
72.19
169.48
14
A
THR
12
-15.58
-53.73
14
A
GLU
13
-44.95
98.01
14
A
ASN
14
169.75
-147.29
14
A
SER
15
176.65
-172.42
14
A
PHE
16
-174.09
143.28
14
A
VAL
19
-39.27
161.28
14
A
LEU
26
72.97
62.97
14
A
ASP
27
165.37
167.94
14
A
ASN
31
-69.18
93.82
14
A
GLU
33
30.74
98.09
14
A
THR
40
-143.68
-58.51
14
A
ASP
48
59.75
16.10
14
A
ALA
62
-157.77
-60.96
14
A
GLU
65
-77.81
-149.82
15
A
THR
2
65.66
96.14
15
A
LYS
9
-45.79
179.11
15
A
HIS
11
-31.32
89.31
15
A
THR
12
85.65
-58.56
15
A
GLU
13
-46.99
97.87
15
A
ASN
14
165.32
-151.05
15
A
SER
15
-179.48
-172.49
15
A
ASN
18
56.43
19.05
15
A
VAL
19
-48.58
161.79
15
A
LEU
26
73.15
66.12
15
A
ASP
27
160.89
173.76
15
A
TYR
32
-111.71
54.24
15
A
GLU
33
28.36
97.36
15
A
VAL
42
-66.00
88.60
15
A
VAL
44
-54.45
106.14
15
A
ALA
62
-172.76
107.94
15
A
PRO
64
-85.53
-84.36
15
A
GLU
65
152.44
53.80
15
A
ASN
66
79.94
-73.24
15
A
ALA
69
-131.30
-83.30
model building
X-PLOR
refinement
X-PLOR
phasing
X-PLOR
MEMBRANE PENETRATION DOMAIN OF THE MINOR COAT PROTEIN G3P OF PHAGE FD, NMR, 15 STRUCTURES
1
Y
N
A
VAL
3
A
VAL
3
HELX_P
A
ALA
8
A
ALA
8
1
1
6
disulf
2.020
A
CYS
6
A
SG
CYS
6
1_555
A
CYS
35
A
SG
CYS
35
1_555
disulf
2.023
A
CYS
45
A
SG
CYS
45
1_555
A
CYS
52
A
SG
CYS
52
1_555
VIRAL PROTEIN
PHAGE COAT PROTEIN, SH3 DOMAIN, PH DOMAIN, PDZ DOMAIN, FD PHAGE, FILAMENTOUS PAHGE, PHAGE INFECTION, PTB DOMAIN, Viral protein
COATA_BPFD
UNP
1
1
P03661
MKKLLFAIPLVVPFYSHSAETVESCLAKPHTENSFTNVWKDDKTLDRYANYEGCLWNATGVVVCTGDETQCYGTWVPIGL
AIPENEGGGSEGGGSEGGGSEGGGTKPPEYGDTPIPGYTYINPLDGTYPPGTEQNPANPNPSLEESQPLNTFMFQNNRFR
NRQGALTVYTGTVTQGTDPVKTYYQYTPVSSKAMYDAYWNGKFRDCAFHSGFNEDPFVCEYQGQSSDLPQPPVNAGGGSG
GGSGGGSEGGGSEGGGSEGGGSEGGGSGGGSGSGDFDYEKMANANKGAMTENADENALQSDAKGKLDSVATDYGAAIDGF
IGDVSGLANGNGATGDFAGSNSQMAQVGDGDNSPLMNNFRQYLPSLPQSVECRPYVFGAGKPYEFSIDCDKINLFRGVFA
FLLYVATFMYVFSTFANILRNKES
20
85
1FGP
1
66
P03661
A
1
1
66
3
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
THR
12
A
THR
12
A
PHE
16
A
PHE
16
A
GLN
51
A
GLN
51
A
TRP
56
A
TRP
56
A
VAL
43
A
VAL
43
A
THR
46
A
THR
46
A
TRP
20
A
TRP
20
A
ASP
22
A
ASP
22
A
ASP
27
A
ASP
27
A
TYR
32
A
TYR
32
A
CYS
35
A
CYS
35
A
ALA
39
A
ALA
39
A
TRP
56
A
TRP
56
A
GLY
60
A
GLY
60
1
P 1